Delivery Order SPE2DB24D2101-SPE2DB25FKMGU
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, valued at $33,612.02. This firm fixed-price delivery order, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Lupron Depot 11.25 mg three-month kits, valued at $34,676.08. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by May 1, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with a contract ceiling value of $14,629.29. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set to be completed by October 29, 2025, and will be fulfilled from the company's facilities in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of October 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical...
- The Defense Logistics Agency awarded a $49,242.84 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with completion scheduled for October 29, 2025. This competitively awarded contract utilizes firm fixed pricing and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $1,534.02 to AmerisourceBergen Drug Corp for Lupron Depot 22.5 mg 3-month kits, with an ultimate completion date of November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Lupron Depot is a hormone treatment used in medical therapies, and...
- The Defense Logistics Agency awarded a delivery order valued at $10,661.96 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was awarded on September 22, 2025 with no set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $7,404.32 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. The contract is structured as a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits valued at $46,242.51 under a firm fixed-price contract type. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Lupron Depot 11.25 mg three-month kits valued at $24,361.39. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order with an ultimate completion date of November 7, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMGUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products, medical devices, and specialized healthcare commodities. Lupron Depot is a hormone treatment medication commonly used in military and federal healthcare settings. AmerisourceBergen's demonstrated capability to fulfill federal medical supply requirements through competitive procurement, combined with its substantial IDC with DLA, positions the company as a primary supplier for federal pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 7/14/25 |